NHS England Spec. Commissioning - Thrombotic Thrombocytopenic Purpura (TTP) all ages (up to 8 Lots)

Publication reference: 2021/S 000-011393
Publication date: 21 May 2021

F02: Contract notice

Section one: Contracting authority

one.1) Name and addresses

NHS England - Specialised Commissioning)

80 London Road

London

SE1 6LH

Email

lisa.innes1@nhs.net

Country

United Kingdom

NUTS code

UK - United Kingdom

Internet address(es)
Main address

https://www.england.nhs.uk/commissioning/spec-services/

Buyer's address

https://www.ardengemcsu.nhs.uk/

one.3) Communication

The procurement documents are available for unrestricted and full direct access, free of charge, at

https://uk.eu-supply.com/login.asp?B=AGCSU&target=

Additional information can be obtained from the above-mentioned address

Tenders or requests to participate must be submitted electronically via

https://uk.eu-supply.com/login.asp?B=AGCSU&target=

Tenders or requests to participate must be submitted to the above-mentioned address

one.4) Type of the contracting authority

Body governed by public law

one.5) Main activity

Health


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

NHS England Spec. Commissioning - Thrombotic Thrombocytopenic Purpura (TTP) all ages (up to 8 Lots)

Reference number

NHSSC-TPP-2021- NHS England

two.1.2) Main CPV code
  • 85100000 - Health services
two.1.3) Type of contract

Services

two.1.4) Short description

Thrombotic Thrombocytopenic Purpura (TTP) is a serious blood disorder that results in blood clots forming in small blood vessels throughout the body. It affects the kidneys, heart and brain. If a patient is treated outside a specialist centre, mortality is 50%; in a specialist centre, it is 20%. There is also an appreciable acute morbidity, particularly in neurological disorders.

The Condition can be difficult to diagnose because initial presentation can be non-specific and this is a very rare disease. Rapid treatment is essential for optimal outcomes and includes plasma exchange and a range of drugs. This disease primarily affects Adults. Children are treated in paediatric haematology centres and are outside the scope of this process.

two.1.5) Estimated total value

Value excluding VAT: £54,943,200

two.1.6) Information about lots

This contract is divided into lots: Yes

Tenders may be submitted for all lots

Maximum number of lots that may be awarded to one tenderer: 1

two.2) Description

two.2.1) Title

Thrombotic Thrombocytopenic Purpura (TTP) – London and the South East (Kent, Surrey, East & West Sussex)

Lot No

1

two.2.2) Additional CPV code(s)
  • 85100000 - Health services
  • 85000000 - Health and social work services
two.2.3) Place of performance
NUTS codes
  • UKJ4 - Kent
  • UKJ2 - Surrey, East and West Sussex
  • UKI - London
Main site or place of performance

London and the South East (Kent, Surrey, East & West Sussex)

two.2.4) Description of the procurement

Thrombotic Thrombocytopenic Purpura (TTP) is a very rare, complex condition which can present as an acute life-threatening disorder that requires prompt diagnosis, early referral and effective immediate management in a centre with comprehensive provision and a multi-discipline approach. Specialist aftercare is also required. There is also a cohort of patients who have a congenital form of the disease who require ongoing apheresis (where a patient’s blood is filtered and then put back into their body). The national prevalence is 330 patients in England, with an acute incidence of 150 patients.

There is a very high mortality rate for patients with this disease: if a patient is treated outside of a specialist centre, the death rate is 50%. There are currently 2 centres in England where there are recognised services and where the survival rate is 80%.

NHS Arden & Greater East Midlands Commissioning Support Unit (AGCSU) on behalf of the Commissioner(s), NHS England - Specialised Commissioning, are looking to commission up to a further 8 Centres across England for TTP services and are inviting interested Providers to bid for these services. The service is a Schedule 3 Service and is being procured under the Light Touch Regime (LTR) of the Public Contract Regulations 2015.

There are patient flows to London from all over the South East. Commissioners have considered establishing one specialist provider for all of London and the South East and this is the default commissioner position.

Commissioners will consider bids for the South East (Thames Valley and Hampshire and Isle of Wight areas - (Lot 2)), to facilitate patient choice and to reduce the requirement to travel for providers who meet the criteria in the service specification, in the technical questionnaire and who are willing to work within a Clinical Partnership with the successful bidder for the London and South East Lot (Lot 1).

The contracting term for these services will be for a period of up to 4 years.

two.2.5) Award criteria

Quality criterion - Name: Section K : Skills and competences / Weighting: 20

Quality criterion - Name: Section L: Managing access and treatment pathway / Weighting: 42

Quality criterion - Name: Section M: Mobilisation / Weighting: 10

Quality criterion - Name: Section N: Education and service continuity / Weighting: 6

Quality criterion - Name: Section O: Clinical outcomes and governance / Weighting: 7

Quality criterion - Name: Section P: Patient satisfaction and patient group / Weighting: 10

Quality criterion - Name: : Section Q: Networks and leadership / Weighting: 5

Price - Weighting: 0

two.2.6) Estimated value

Value excluding VAT: £20,589,200

two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months

48

This contract is subject to renewal

No

two.2.10) Information about variants

Variants will be accepted: No

two.2.11) Information about options

Options: No

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No

two.2.14) Additional information

Please note that Lots may have changed from previous publications.

two.2) Description

two.2.1) Title

Thrombotic Thrombocytopenic Purpura (TTP) - South East (Thames Valley, Hampshire and the Isle of Wight)

Lot No

2

two.2.2) Additional CPV code(s)
  • 85000000 - Health and social work services
  • 85100000 - Health services
two.2.3) Place of performance
NUTS codes
  • UKJ - South East (England)
Main site or place of performance

South East (Thames Valley, Hampshire and the Isle of Wight)

two.2.4) Description of the procurement

Thrombotic Thrombocytopenic Purpura (TTP) is a very rare, complex condition which can present as an acute life-threatening disorder that requires prompt diagnosis, early referral and effective immediate management in a centre with comprehensive provision and a multi-discipline approach. Specialist aftercare is also required. There is also a cohort of patients who have a congenital form of the disease who require ongoing apheresis (where a patient’s blood is filtered and then put back into their body). The national prevalence is 330 patients in England, with an acute incidence of 150 patients.

There is a very high mortality rate for patients with this disease: if a patient is treated outside of a specialist centre, the death rate is 50%. There are currently 2 centres in England where there are recognised services and where the survival rate is 80%.

NHS Arden & Greater East Midlands Commissioning Support Unit (AGCSU) on behalf of the Commissioner(s), NHS England - Specialised Commissioning, are looking to commission up to a further 8 Centres across England for TTP services and are inviting bids for these services. The service is a Schedule 3 Service and is being procured under the Light Touch Regime (LTR) of the Public Contract Regulations 2015.

The contracting term for these services will be for a period of up to 4 years.

two.2.5) Award criteria

Quality criterion - Name: Section K : Skills and competences / Weighting: 20

Quality criterion - Name: Section L: Managing access and treatment pathway / Weighting: 42

Quality criterion - Name: Section M: Mobilisation / Weighting: 10

Quality criterion - Name: Section N: Education and service continuity / Weighting: 6

Quality criterion - Name: Section O: Clinical outcomes and governance / Weighting: 7

Quality criterion - Name: Section P: Patient satisfaction and patient group / Weighting: 10

Quality criterion - Name: Section Q: Networks and leadership / Weighting: 5

Price - Weighting: 0

two.2.6) Estimated value

Value excluding VAT: £4,173,800

two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months

48

This contract is subject to renewal

No

two.2.10) Information about variants

Variants will be accepted: No

two.2.11) Information about options

Options: No

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No

two.2.14) Additional information

Please note that Lots may have changed from previous publications.

two.2) Description

two.2.1) Title

Thrombotic Thrombocytopenic Purpura (TTP) - West Midlands

Lot No

3

two.2.2) Additional CPV code(s)
  • 85000000 - Health and social work services
  • 85100000 - Health services
two.2.3) Place of performance
NUTS codes
  • UKG - West Midlands (England)
Main site or place of performance

West Midlands

two.2.4) Description of the procurement

Thrombotic Thrombocytopenic Purpura (TTP) is a very rare, complex condition which can present as an acute life-threatening disorder that requires prompt diagnosis, early referral and effective immediate management in a centre with comprehensive provision and a multi-discipline approach. Specialist aftercare is also required. There is also a cohort of patients who have a congenital form of the disease who require ongoing apheresis (where a patient’s blood is filtered and then put back into their body). The national prevalence is 330 patients in England, with an acute incidence of 150 patients.

There is a very high mortality rate for patients with this disease: if a patient is treated outside of a specialist centre, the death rate is 50%. There are currently 2 centres in England where there are recognised services and where the survival rate is 80%.

NHS Arden & Greater East Midlands Commissioning Support Unit (AGCSU) on behalf of the Commissioner(s), NHS England - Specialised Commissioning, are looking to commission up to a further 8 Centres across England for TTP services and are inviting bids for these services. The service is a Schedule 3 Service and is being procured under the Light Touch Regime (LTR) of the Public Contract Regulations 2015.

The contracting term for these services will be for a period of up to 4 years

two.2.5) Award criteria

Quality criterion - Name: Section K : Skills and competences / Weighting: 20

Quality criterion - Name: Section L: Managing access and treatment pathway / Weighting: 42

Quality criterion - Name: Section M: Mobilisation / Weighting: 10

Quality criterion - Name: Section N: Education and service continuity / Weighting: 6

Quality criterion - Name: Section O: Clinical outcomes and governance / Weighting: 7

Quality criterion - Name: Section P: Patient satisfaction and patient group / Weighting: 10

Quality criterion - Name: Section Q: Networks and leadership / Weighting: 5

Price - Weighting: 0

two.2.6) Estimated value

Value excluding VAT: £7,633,000

two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months

48

This contract is subject to renewal

No

two.2.10) Information about variants

Variants will be accepted: No

two.2.11) Information about options

Options: No

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No

two.2.14) Additional information

Please note that Lots may have changed from previous publications.

two.2) Description

two.2.1) Title

Thrombotic Thrombocytopenic Purpura (TTP) - East Midlands

Lot No

4

two.2.2) Additional CPV code(s)
  • 85000000 - Health and social work services
  • 85100000 - Health services
two.2.3) Place of performance
NUTS codes
  • UKF - East Midlands (England)
Main site or place of performance

East Midlands

two.2.4) Description of the procurement

Thrombotic Thrombocytopenic Purpura (TTP) is a very rare, complex condition which can present as an acute life-threatening disorder that requires prompt diagnosis, early referral and effective immediate management in a centre with comprehensive provision and a multi-discipline approach. Specialist aftercare is also required. There is also a cohort of patients who have a congenital form of the disease who require ongoing apheresis (where a patient’s blood is filtered and then put back into their body). The national prevalence is 330 patients in England, with an acute incidence of 150 patients.

There is a very high mortality rate for patients with this disease: if a patient is treated outside of a specialist centre, the death rate is 50%. There are currently 2 centres centre in England where there are recognised services and where the survival rate is 80%.

NHS Arden & Greater East Midlands Commissioning Support Unit (AGCSU) on behalf of the Commissioner(s), NHS England - Specialised Commissioning, are looking to commission up to a further 8 Centres across England for TTP services and are inviting bids for these services. The service is a Schedule 3 Service and is being procured under the Light Touch Regime (LTR) of the Public Contract Regulations 2015.

The contracting term for these services will be for a period of up to 4 years.

two.2.5) Award criteria

Quality criterion - Name: Section K : Skills and competences / Weighting: 20

Quality criterion - Name: Section L: Managing access and treatment pathway / Weighting: 42

Quality criterion - Name: : Section M: Mobilisation / Weighting: 10

Quality criterion - Name: Section N: Education and service continuity / Weighting: 6

Quality criterion - Name: Section O: Clinical outcomes and governance / Weighting: 7

Quality criterion - Name: Section P: Patient satisfaction and patient group / Weighting: 10

Quality criterion - Name: Section Q: Networks and leadership / Weighting: 5

Price - Weighting: 0

two.2.6) Estimated value

Value excluding VAT: £4,041,100

two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months

48

This contract is subject to renewal

No

two.2.10) Information about variants

Variants will be accepted: No

two.2.11) Information about options

Options: No

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No

two.2.14) Additional information

Please note that Lots may have changed from previous publications.

two.2) Description

two.2.1) Title

Thrombotic Thrombocytopenic Purpura (TTP) - East of England

Lot No

5

two.2.2) Additional CPV code(s)
  • 85000000 - Health and social work services
  • 85100000 - Health services
two.2.3) Place of performance
NUTS codes
  • UKH - East of England
Main site or place of performance

East of England

two.2.4) Description of the procurement

Thrombotic Thrombocytopenic Purpura (TTP) is a very rare, complex condition which can present as an acute life-threatening disorder that requires prompt diagnosis, early referral and effective immediate management in a centre with comprehensive provision and a multi-discipline approach. Specialist aftercare is also required. There is also a cohort of patients who have a congenital form of the disease who require ongoing apheresis (where a patient’s blood is filtered and then put back into their body). The national prevalence is 330 patients in England, with an acute incidence of 150 patients.

There is a very high mortality rate for patients with this disease: if a patient is treated outside of a specialist centre, the death rate is 50%. There are currently 2 centres in England where there are recognised services and where the survival rate is 80%.

NHS Arden & Greater East Midlands Commissioning Support Unit (AGCSU) on behalf of the Commissioner(s), NHS England - Specialised Commissioning, are looking to commission up to a further 8 Centres across England for TTP services and are inviting bids for these services. The service is a Schedule 3 Service and is being procured under the Light Touch Regime (LTR) of the Public Contract Regulations 2015.

The contracting term for these services will be for a period of up to 4 years.

two.2.5) Award criteria

Quality criterion - Name: Section K : Skills and competences / Weighting: 20

Quality criterion - Name: Section L: Managing access and treatment pathway / Weighting: 42

Quality criterion - Name: Section M: Mobilisation / Weighting: 10

Quality criterion - Name: Section N: Education and service continuity / Weighting: 6

Quality criterion - Name: Section O: Clinical outcomes and governance / Weighting: 7

Quality criterion - Name: Section P: Patient satisfaction and patient group / Weighting: 10

Quality criterion - Name: Section Q: Networks and leadership / Weighting: 5

Price - Weighting: 0

two.2.6) Estimated value

Value excluding VAT: £4,017,500

two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months

48

This contract is subject to renewal

No

two.2.10) Information about variants

Variants will be accepted: No

two.2.11) Information about options

Options: No

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No

two.2.14) Additional information

Please note that Lots may have changed from previous publications.

two.2) Description

two.2.1) Title

Thrombotic Thrombocytopenic Purpura (TTP) - North East

Lot No

6

two.2.2) Additional CPV code(s)
  • 85000000 - Health and social work services
  • 85100000 - Health services
two.2.3) Place of performance
NUTS codes
  • UKC - North East (England)
Main site or place of performance

North East

two.2.4) Description of the procurement

Thrombotic Thrombocytopenic Purpura (TTP) is a very rare, complex condition which can present as an acute life-threatening disorder that requires prompt diagnosis, early referral and effective immediate management in a centre with comprehensive provision and a multi-discipline approach. Specialist aftercare is also required. There is also a cohort of patients who have a congenital form of the disease who require ongoing apheresis (where a patient’s blood is filtered and then put back into their body). The national prevalence is 330 patients in England, with an acute incidence of 150 patients.

There is a very high mortality rate for patients with this disease: if a patient is treated outside of a specialist centre, the death rate is 50%. There are currently 2 centres in England where there are recognised services and where the survival rate is 80%.

NHS Arden & Greater East Midlands Commissioning Support Unit (AGCSU) on behalf of the Commissioner(s), NHS England - Specialised Commissioning, are looking to commission up to a further 8 Centres across England for TTP services and are inviting bids for these services. The service is a Schedule 3 Service and is being procured under the Light Touch Regime (LTR) of the Public Contract Regulations 2015.

The contracting term for these services will be for a period of up to 4 years.

two.2.5) Award criteria

Quality criterion - Name: Section K : Skills and competences / Weighting: 20

Quality criterion - Name: Section L: Managing access and treatment pathway / Weighting: 42

Quality criterion - Name: Section M: Mobilisation / Weighting: 10

Quality criterion - Name: Section N: Education and service continuity / Weighting: 6

Quality criterion - Name: Section O: Clinical outcomes and governance / Weighting: 7

Quality criterion - Name: Section P: Patient satisfaction and patient group / Weighting: 10

Quality criterion - Name: Section Q: Networks and leadership / Weighting: 5

Price - Weighting: 0

two.2.6) Estimated value

Value excluding VAT: £40,002,800

two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months

48

This contract is subject to renewal

No

two.2.10) Information about variants

Variants will be accepted: No

two.2.11) Information about options

Options: No

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No

two.2.14) Additional information

Please note that Lots may have changed from previous publications.

two.2) Description

two.2.1) Title

Thrombotic Thrombocytopenic Purpura (TTP) - Yorkshire and the Humber

Lot No

7

two.2.2) Additional CPV code(s)
  • 85000000 - Health and social work services
  • 85100000 - Health services
two.2.3) Place of performance
NUTS codes
  • UKE - Yorkshire and the Humber
Main site or place of performance

Yorkshire and the Humber

two.2.4) Description of the procurement

Thrombotic Thrombocytopenic Purpura (TTP) is a very rare, complex condition which can present as an acute life-threatening disorder that requires prompt diagnosis, early referral and effective immediate management in a centre with comprehensive provision and a multi-discipline approach. Specialist aftercare is also required. There is also a cohort of patients who have a congenital form of the disease who require ongoing apheresis (where a patient’s blood is filtered and then put back into their body). The national prevalence is 330 patients in England, with an acute incidence of 150 patients.

There is a very high mortality rate for patients with this disease: if a patient is treated outside of a specialist centre, the death rate is 50%. There are currently 2 centres in England where there are recognised services and where the survival rate is 80%.

NHS Arden & Greater East Midlands Commissioning Support Unit (AGCSU) on behalf of the Commissioner(s), NHS England - Specialised Commissioning, are looking to commission up to a further 8 Centres across England for TTP services and are inviting bids for these services. The service is a Schedule 3 Service and is being procured under the Light Touch Regime (LTR) of the Public Contract Regulations 2015.

The contracting term for these services will be for a period of up to 4 years

two.2.5) Award criteria

Quality criterion - Name: Section K : Skills and competences / Weighting: 20

Quality criterion - Name: Section L: Managing access and treatment pathway / Weighting: 42

Quality criterion - Name: Section M: Mobilisation / Weighting: 10

Quality criterion - Name: Section N: Education and service continuity / Weighting: 6

Quality criterion - Name: Section O: Clinical outcomes and governance / Weighting: 7

Quality criterion - Name: Section P: Patient satisfaction and patient group / Weighting: 10

Quality criterion - Name: Section Q: Networks and leadership / Weighting: 5

Price - Weighting: 0

two.2.6) Estimated value

Value excluding VAT: £4,851,400

two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months

48

This contract is subject to renewal

No

two.2.10) Information about variants

Variants will be accepted: No

two.2.11) Information about options

Options: No

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No

two.2.14) Additional information

Please note that Lots may have changed from previous publications.

two.2) Description

two.2.1) Title

Thrombotic Thrombocytopenic Purpura (TTP) - South West

Lot No

8

two.2.2) Additional CPV code(s)
  • 85000000 - Health and social work services
  • 85100000 - Health services
two.2.3) Place of performance
NUTS codes
  • UKK - South West (England)
two.2.4) Description of the procurement

Thrombotic Thrombocytopenic Purpura (TTP) is a very rare, complex condition which can present as an acute life-threatening disorder that requires prompt diagnosis, early referral and effective immediate management in a centre with comprehensive provision and a multi-discipline approach. Specialist aftercare is also required. There is also a cohort of patients who have a congenital form of the disease who require ongoing apheresis (where a patient’s blood is filtered and then put back into their body). The national prevalence is 330 patients in England, with an acute incidence of 150 patients.

There is a very high mortality rate for patients with this disease: if a patient is treated outside of a specialist centre, the death rate is 50%. There are currently 2 centres in England where there are recognised services and where the survival rate is 80%.

NHS Arden & Greater East Midlands Commissioning Support Unit (AGCSU) on behalf of the Commissioner(s), NHS England - Specialised Commissioning, are looking to commission up to a further 8 Centres across England for TTP services and are inviting bids for these services. The service is a Schedule 3 Service and is being procured under the Light Touch Regime (LTR) of the Public Contract Regulations 2015.

The contracting term for these services will be for a period of up to 4 years

two.2.5) Award criteria

Quality criterion - Name: Section K : Skills and competences / Weighting: 20

Quality criterion - Name: Section L: Managing access and treatment pathway / Weighting: 42

Quality criterion - Name: Section M: Mobilisation / Weighting: 10

Quality criterion - Name: Section N: Education and service continuity / Weighting: 6

Quality criterion - Name: Section O: Clinical outcomes and governance / Weighting: 7

Quality criterion - Name: Section P: Patient satisfaction and patient group / Weighting: 10

Quality criterion - Name: Section Q: Networks and leadership / Weighting: 5

Price - Weighting: 0

two.2.6) Estimated value

Value excluding VAT: £5,634,400

two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months

48

This contract is subject to renewal

No

two.2.10) Information about variants

Variants will be accepted: No

two.2.11) Information about options

Options: No

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No

two.2.14) Additional information

Please note that Lots may have changed from previous publications.


Section three. Legal, economic, financial and technical information

three.1) Conditions for participation

three.1.3) Technical and professional ability
List and brief description of selection criteria

All technical capacity and its evaluation criteria are specified within the tender documentation.


Section four. Procedure

four.1) Description

four.1.1) Type of procedure

Open procedure

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes

four.2) Administrative information

four.2.1) Previous publication concerning this procedure

Notice number: 2021/S 000-006895

four.2.2) Time limit for receipt of tenders or requests to participate
Date

25 June 2021

Local time

5:00pm

four.2.4) Languages in which tenders or requests to participate may be submitted

English

four.2.7) Conditions for opening of tenders
Date

25 June 2021

Local time

5:00pm


Section six. Complementary information

six.1) Information about recurrence

This is a recurrent procurement: No

six.3) Additional information

In response to a recommendation from the Prescribed Specialised Services Advisory Group in 2014, NHS England developed a service model that aimed to balance the high levels of multi-disciplinary expertise required to treat patients with TTP with the requirement for patients to be treated rapidly to have optimal outcomes. NHS England undertook a public consultation on the draft service specification, which closed in October 2018. The consultation documents are still available on the NHS England website at this link:

Consultation on service specifications for thrombotic thrombocytopenic purpura (TTP) for all ages - NHS England - Citizen Space.

The model of delivery is to offer in-patient care within a specialist TTP centre, Patients with TTP require lifelong monitoring and follow up to manage relapse. Shared care is possible, based on the preference of the patient. Specialist TTP centres are required to undertake a clinical leadership, proactive education and outreach service to hospitals within their region to improve the identification of patients with TTP and the timely referral of patients to the specialist TTP centres. Specialist TTP centres are required to establish robust clinical partnerships with paediatric haematology centres to provide support in relation to the treatment of children and to agree a transition policy.

There are patient flows to London from all over the South East. Commissioners have considered establishing one provider for all of London and the South East and this is the default Commissioner position. Commissioners will consider bids for the South East (Thames Valley and Hampshire and Isle of Wight areas, (Lot 2)) to facilitate patient choice and to reduce the requirement to travel for providers who meet the criteria in the service specification, in the technical questionnaire and who are willing to work within a Clinical Partnership with the successful bidder for the London and South East Lot (Lot 1).

This will support effective care and improve local patient access to the service whilst ensuring availability of clinical expertise as appropriate.

To register your interest in these services please follow this link https://uk.eu-supply.com/ctm/supplier/publictenders?B=UK and either login or register on EU Supply and search from ID number 43998. All Bidders are asked to complete the general Qualification and Technical questions and the Lot specific Qualification and Technical Questions for the Lots they are applying for. Bidders may apply for more than one Lot, but will only be awarded a maximum of one Lot. Please refer to the Process Selection Process Overview documents for further details.

six.4) Procedures for review

six.4.1) Review body

Arden & GEM Commissioning Support Unit

Derby

DE1 3QT

Country

United Kingdom

six.4.2) Body responsible for mediation procedures

Arden & GEM Commissioning Support Unit

Derby

DE1 3QT

Country

United Kingdom

six.4.4) Service from which information about the review procedure may be obtained

Arden & GEM Commissioning Support Unit

Derby

DE1 3QT

Country

United Kingdom